- Price
- $206.25
- Day
- +1.21%
- Mkt Cap
- $33.50B
- 52W Range
- $148.05 – $310.50
- Volume
- 2.61M
- Beta
- 0.94
Find a company by name or ticker and open its page
Snapshot of fundamentals, performance, and 5D scores.
Business fundamentals and company information
Recent price action and historical returns
How the business makes money, by product and geography
Five lenses on the stock. Click any card to dive deeper.
How to read these dimensions
The five dimensions are independent lenses on a company, not a single combined score. Read them together rather than in isolation: where one dimension scores differently from the others is often the most useful place to focus your own research. Each score is built from rules and weights you can adjust, so treat them as a transparent starting point for your analysis, not a recommendation to buy or sell.
Recent news headlines and analyst price-target moves
Veeva Systems: A 'Buy' Because The Narrative Has Outrun The Fundamentals
Veeva Systems has underperformed the S&P 500 despite strong fundamentals and improving profitability. VEEV's revenue grew 16% year-over-year, gross profit rose to the mid-70s, and cash generation nearly doubled to $1.665 billion TTM. The transition from Salesforce to Vault CRM is progressing, but AI initiative ROI doubts and migration risks weigh on sentiment.
Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or Invesco's Equal-Weight RSPH?
FHLC's 0.08% expense ratio and market-cap approach delivered stronger returns, while RSPH's equal-weight strategy offers lower volatility and broader diversification across 60 holdings.
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors
The latest trading day saw Veeva Systems (VEEV) settling at $201.56, representing a -3.05% change from its previous close.
Veeva Systems Inc. $VEEV Shares Sold by American Capital Management Inc.
American Capital Management Inc. cut its position in shares of Veeva Systems Inc. (NYSE: VEEV) by 7.3% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 206,218 shares of the technology company's stock after selling 16,207 shares during the quarter. Veeva Systems
Philip Morris: Firing On All Cylinders
Philip Morris delivered strong Q2 results last week with double-digit net revenue and gross profit growth driven by IQOS and VEEV products. IQOS heated tobacco and VEEV vape brands are fueling significant top-line expansion and margin uplift, mainly because of strong shipment growth. PM trades at a forward P/E of 21.2x, much higher than MO or BTI, reflecting its focus on emerging markets and superior EPS growth prospects.